Compounds > 6-aminonicotinamide
Page last updated: 2024-08-21

6-aminonicotinamide and Experimental Mammary Neoplasms

6-aminonicotinamide has been researched along with Experimental Mammary Neoplasms in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's8 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DIETRICH, LS1
Colofiore, JR; Martin, DS; Nord, LD; Sternberg, S; Stolfi, RL1
Colofiore, JR; Martin, DS; Nord, LD; Stolfi, RL2
Ballon, D; Koutcher, JA; Mahmood, U; Martin, DS; Matei, C; Street, JC1
Alfieri, AA; Koutcher, JA; Martin, DS; Matei, C; Meyer, KL; Street, JC1
Alfieri, AA; Ballon, D; Koutcher, JA; Martin, DS; Matei, C; Stolfi, RL; Tsai, JC1
Alfieri, AA; Colofiore, JR; Koutcher, JA; Martin, DS; Netto, G; Nord, LD; Reuter, V; Sternberg, SS; Stolfi, RL1
Colofiore, JR; Koutcher, JA; Martin, DS; Nord, LD; Stolfi, RL1
Martin, DS1

Other Studies

10 other study(ies) available for 6-aminonicotinamide and Experimental Mammary Neoplasms

ArticleYear
AUGMENTATION OF 6-AMINONICOTINAMIDE ANTAGONISM OF TUMOR GROWTH BY COMPOUNDS WITH ESTROGENIC ACTIVITY.
    Cancer research, 1964, Volume: 24

    Topics: 6-Aminonicotinamide; Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Cortisone; Diethylstilbestrol; Estradiol; Estrone; Hexestrol; Humans; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Niacinamide; Pathology; Pharmacology; Phloretin; Progesterone; Propiophenones; Research

1964
Biochemical modulation of tumor cell energy in vivo: II. A lower dose of adriamycin is required and a greater antitumor activity is induced when cellular energy is depressed.
    Cancer investigation, 1994, Volume: 12, Issue:3

    Topics: 6-Aminonicotinamide; Animals; Apoptosis; Aspartic Acid; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Energy Metabolism; Mammary Neoplasms, Experimental; Methylthioinosine; Phosphonoacetic Acid

1994
Correlation of retention of tumor methylmercaptopurine riboside-5'-phosphate with effectiveness in CD8F1 murine mammary tumor regression.
    Biochemical pharmacology, 1996, Mar-08, Volume: 51, Issue:5

    Topics: 6-Aminonicotinamide; Adenosine Kinase; Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Phosphonoacetic Acid

1996
In vivo detection by 31P NMR of pentose phosphate pathway block secondary to biochemical modulation.
    NMR in biomedicine, 1996, Volume: 9, Issue:3

    Topics: 6-Aminonicotinamide; Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cell Division; Magnetic Resonance Spectroscopy; Male; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Mice, Inbred C3H; Pentose Phosphate Pathway; Phosphonoacetic Acid; Phosphorus; Teratogens

1996
Marked enhancement in vivo of paclitaxel's (taxol's) tumor-regressing activity by ATP-depleting modulation.
    Anti-cancer drugs, 1996, Volume: 7, Issue:6

    Topics: 6-Aminonicotinamide; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Paclitaxel; Phosphonoacetic Acid; Remission Induction

1996
Effect of 6-aminonicotinamide on the pentose phosphate pathway: 31P NMR and tumor growth delay studies.
    Magnetic resonance in medicine, 1996, Volume: 36, Issue:6

    Topics: 6-Aminonicotinamide; Adenocarcinoma; Animals; Combined Modality Therapy; Female; Gluconates; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Pentose Phosphate Pathway; Phosphorus Radioisotopes; Teratogens

1996
Evaluation of chemotherapy and radiation enhancement and 31P NMR spectral changes induced by biochemical modulation.
    Cancer investigation, 1997, Volume: 15, Issue:2

    Topics: 6-Aminonicotinamide; Animals; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cell Division; Disease Progression; Doxorubicin; Drug Synergism; Evaluation Studies as Topic; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Phosphorus Isotopes; Radiation-Sensitizing Agents

1997
Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletion.
    Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:5

    Topics: 6-Aminonicotinamide; Adenosine Triphosphate; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspartic Acid; Female; Mammary Neoplasms, Experimental; Mercaptopurine; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Phosphonoacetic Acid; Time Factors

1997
Biochemical modulation of tumor cell energy: regression of advanced spontaneous murine breast tumors with a 5-fluorouracil-containing drug combination.
    Cancer research, 1992, Aug-01, Volume: 52, Issue:15

    Topics: 6-Aminonicotinamide; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Fluorouracil; Mammary Neoplasms, Experimental; Methylthioinosine; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Orotic Acid; Phosphonoacetic Acid; Phosphoribosyl Pyrophosphate

1992
Cancer chemotherapy: past is prologue.
    The Mount Sinai journal of medicine, New York, 1985, Volume: 52, Issue:6

    Topics: 6-Aminonicotinamide; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Fluorouracil; Humans; Male; Mammary Neoplasms, Experimental; Methotrexate; Methylthioinosine; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Phosphonoacetic Acid

1985